The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease
Open accessAbstract
standardized mortality ratio; TNF, tumor necrosis factor; TZD, thiazolidinedione; ULN, upper limit of normal.A table elsewhere in this issue shows conventional and Syste
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Hotta, K., Funahashi, T., Bodkin, N. L., Ortmeyer, H. K., Arita, Y., Hansen, B. C., & Matsuzawa, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1126 · Cited by 1,072
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M., & Weinman, S. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.30983 · Cited by 926
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Insulin-like growth factor II receptor as a multifunctional binding protein
Morgan, D. O., Edman, J. C., Standring, D. N., Fried, V. A., Smith, M. C., Roth, R. A., & Rutter, W. J. (1987) · Nature · doi:10.1038/329301a0 · Cited by 853
Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 840
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Crespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Metformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., & Thomas, D. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00009 · Cited by 676
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Wideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1360 · Cited by 627
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 609
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 550
Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63408-6 · Cited by 536
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)05040-x · Cited by 531
Tiikkainen, M., Häkkinen, A.-M., Korsheninnikova, E., Nyman, T., Mäkimattila, S., & Yki-Järvinen, H. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2169 · Cited by 524
Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
Joseph, A. E. A., Saverymuttu, S. H., Al-Sam, S., Cook, M. G., & Maxwell, J. D. (1991) · Clinical Radiology · doi:10.1016/s0009-9260(05)80350-2 · Cited by 515
Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E
Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., & McClain, C. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50316 · Cited by 504
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 501
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489
Alcohollike liver disease in nonalcoholics
Diehl, A. M., Goodman, Z., & Ishak, K. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90183-7 · Cited by 483
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
Lonardo, A., Adinolfi, L. E., Loria, P., Carulli, N., Ruggiero, G., & Day, C. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.020 · Cited by 477
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Allison, M. E. D., Wreghitt, T., Palmer, C. R., & Alexander, G. J. M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80631-2 · Cited by 454
Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J., Emick, D., Lok, A. S., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 444
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
Chalasani, N., Aljadhey, H., Kesterson, J., Murray, M. D., & Hall, S. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.015 · Cited by 441
Abdelmalek, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02691-0 · Cited by 439
Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Hickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D. M., Clouston, A. D., & Powell, E. E. (2004) · Gut · doi:10.1136/gut.2003.027581 · Cited by 435
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
Hepatic effects of dietary weight loss in morbidly obese subjects
Andersen, T., Gluud, C., Franzmann, M.-B., & Christoffersen, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90942-5 · Cited by 407
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
de Marco, R., Locatelli, F., Zoppini, G., Verlato, G., Bonora, E., & Muggeo, M. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.756 · Cited by 405
Metformin in the treatment of patients with non‐alcoholic steatohepatitis
Uygun, A., Kadayifci, A., Isik, A. T., Ozgurtas, T., Deveci, S., Tuzun, A., Yesilova, Z., Gulsen, M., & Dagalp, K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01888.x · Cited by 405
Hepatitis C Virus Infection and Incident Type 2 Diabetes
Mehta, S. H., Brancati, F. L., Strathdee, S. A., Pankow, J. S., Netski, D., Coresh, J., Szklo, M., & Thomas, D. L. (2003) · Hepatology · doi:10.1053/jhep.2003.50291 · Cited by 404
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
Longo, R., Pollesello, P., Ricci, C., Masutti, F., Kvam, B. J., Bercich, L., Croce, L. S., Grigolato, P., Paoletti, S., De Bernard, B., et al. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050311 · Cited by 387
Effect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
Excess Risk of Primary Liver Cancer in Patients With Diabetes Mellitus
Adami, H.-O., Chow, W.-H., Nyren, O., Berne, C., Linet, M. S., Ekbom, A., Wolk, A., McLaughlin, J. K., & Fraumeni, J. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1472 · Cited by 373
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., & Perrillo, R. P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02025.x · Cited by 369
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
Suzuki, A., Lindor, K., Saver, J. S., Lymp, J., Mendes, F., Muto, A., Okada, T., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.008 · Cited by 319
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
Basaranoglu, M., Acbay, O., & Sonsuz, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80243-8 · Cited by 305
Liver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Liver disease and diabetes mellitus.
Na, B., Herrine, S. K., & Rubin, R. A. (2001) · PubMed · Cited by 299
Drenick, E. J., Simmons, F., & Murphy, J. F. (1970) · New England Journal of Medicine · doi:10.1056/nejm197004092821502 · Cited by 291
Bajaj, M., Suraamornkul, S., Pratipanawatr, T., Hardies, L. J., Pratipanawatr, W., Glass, L., Cersosimo, E., Miyazaki, Y., & DeFronzo, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1364 · Cited by 290
High Prevalence of Hepatitis C Virus Infection in Diabetic Patients
Simó, R., Hernández, C., Genescà, J., Jardí, R., & Mesa, J. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.998 · Cited by 275
Leonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogl, S., Dargel, R., & Poli, G. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.11.9285483 · Cited by 264
Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis†
Petrides, A. S., Vogt, C., Schulze-Berge, D., Matthews, D., & Strohmeyer, G. (1994) · Hepatology · doi:10.1002/hep.1840190312 · Cited by 262
Hultcrantz, R., Glaumann, H., Lindberg, G., & H:son Nilsson, L. (1986) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528609034632 · Cited by 261
REVIEW: Nonalcoholic steatohepatitis
LUDWIG, J., McGILL, D. B., & LINDOR, K. D. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00450.x · Cited by 248
A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis
Adams, L. A., Zein, C. O., Angulo, P., & Lindor, K. D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40064.x · Cited by 234
Pinto, H. C., Baptista, A., Camilo, M. E., Valente, A., Saragoça, A., & de Moura, M. C. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02208601 · Cited by 219
Evaluation of Liver Function in Type 2 Diabetic Patients During Clinical Trials
Lebovitz, H. E., Kreider, M., & Freed, M. I. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.815 · Cited by 218
Tolman, K. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02355-x · Cited by 214
Self-citationDietary Composition and Nonalcoholic Fatty Liver Disease
Solga, S., Alkhuraishe, A. R., Clark, J. M., Torbenson, M., Greenwald, A., Diehl, A. M., & Magnuson, T. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000043367.69470.b7 · Cited by 213
Hepatic Failure in a Patient Taking Rosiglitazone
Forman, L. M., Simmons, D. A., & Diamond, R. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00005 · Cited by 212
Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
Kiyici, M., Gulten, M., Gurel, S., Nak, S. G., Dolar, E., Savci, G., Adim, S. B., Yerci, O., & Memik, F. (2003) · Canadian Journal of Gastroenterology · doi:10.1155/2003/857869 · Cited by 199
Nonalcoholic Steatohepatitis in Obesity: A Reversible Condition
ERIKSSON, S., ERIKSSON, K., & BONDESSON, L. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02733.x · Cited by 198
Nonalcoholic fatty liver disease in the pediatric population
Lavine, J. E., & Schwimmer, J. B. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.010 · Cited by 198
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Al-Salman, J., Arjomand, H., Kemp, D. G., & Mittal, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00006 · Cited by 196
A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients
Harrison, S. A., Fincke, C., Helinski, D., Torgerson, S., & Hayashi, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02153.x · Cited by 191
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
Clark, J. M., Alkhuraishi, A. R. A., Solga, S. F., Alli, P., Diehl, A. M., & Magnuson, T. H. (2005) · Obesity Research · doi:10.1038/oby.2005.140 · Cited by 184
Kang, H., Greenson, J. K., Omo, J. T., Chao, C., Peterman, D., Anderson, L., Foess-Wood, L., Sherbondy, M. A., & Conjeevaram, H. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00719.x · Cited by 180
Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection
Hui, J. M., Kench, J., Farrell, G. C., Lin, R., Samarasinghe, D., Liddle, C., Byth, K., & George, J. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02813.x · Cited by 178
Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
Itoh, S., Yougel, T., & Kawagoe, K. (1987) · PubMed · Cited by 174
Diabetes increases the risk of acute hepatic failure
El–Serag, H. B., & Everhart, J. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.33650 · Cited by 174
Sabile, A., Perlemuter, G., Bono, F., Kohara, K., Demaugre, F., Kohara, M., Matsuura, Y., Miyamura, T., Bréchot, C., & Barba, G. (1999) · Hepatology · doi:10.1002/hep.510300429 · Cited by 173
Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy
May, L. D., Lefkowitch, J. H., Kram, M. T., & Rubin, D. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-6-200203190-00008 · Cited by 167
Douketis, J. D., Feightner, J., Attia, J., & Feldman, W. F. (1999) · Europe PMC (PubMed Central) · Cited by 159
Effect of Interferon on Glucose Tolerance and Insulin Sensitivity
Koivisto, V. A., Pelkonen, R., & Cantell, K. (1989) · Diabetes · doi:10.2337/diab.38.5.641 · Cited by 153
Marks, V., & Teale, J. D. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70088-8 · Cited by 150
Liver morphology and function tests in obesity and during total starvation
Rozental, P., Biava, C. G., Spencer, H., & Zimmerman, H. J. (1967) · Digestive Diseases and Sciences · doi:10.1007/bf02233443 · Cited by 142
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
Fabris, P., Floreani, A., Tositti, G., Vergani, D., de Lalla, F., & Betterle, C. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01681.x · Cited by 132
A randomized controlled trial of acarbose in hepatic encephalopathy
Gentile, S., Guarino, G., Romano, M., Alagia, I., Fierro, M., Annunziata, S., Magliano, P. L., Gravina, A. G., & Torella, R. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00667-6 · Cited by 132
Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus
Tolman, K. G., Fonseca, V. A., Tan, M. H., & Dalpiaz, A. S. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-12-200412210-00011 · Cited by 130
Self-citationDurante‐Mangoni, E., Zampino, R., Marrone, A., Tripodi, M., Rinaldi, L., Restivo, L., Cioffi, M., Ruggiero, G., & Adinolfi, L. E. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03114.x · Cited by 129
Gray, H., Wreghitt, T. G., STRATTON, I. M., Alexander, G., Turner, R. C., & O’Rahilly, S. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00466.x · Cited by 129
Rubbia-Brandt, L., Leandro, G., Spahr, L., Giostra, E., Quadri, R. A., Malé, P. J., & Negro, F. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01208.x · Cited by 129
Higher Incidence of Diabetes in Liver Transplant Recipients With Hepatitis C
Knobler, H., Stagnaro‐Green, A., Wallenstein, S. R., Schwartz, M., & Roman, S. H. (1998) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199801000-00009 · Cited by 129
Neuschwander‐Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Sponseller, C. A., Hampton, K., & Bacon, B. R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00027-8 · Cited by 118
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study
Trombetta, M., Spiazzi, G., Zoppini, G., & Muggeo, M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02590.x · Cited by 114
Konrád, Zeuzem, Vicini, Toffolo, Briem, Lormann, Herrmann, Berger, Kusterer, Teuber, et al. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00608.x · Cited by 96
Acarbose-induced acute severe hepatotoxicity
Carrascosa, M. F., Pascual, F., & Zárate, S. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60134-1 · Cited by 93
Mayoral, W., Lewis, J. H., & Zimmerman, H. J. (1999) · Current Opinion in Gastroenterology · doi:10.1097/00001574-199905000-00005 · Cited by 91
Lutchman, G. A., Promrat, K., Kleiner, D. E., Heller, T., Ghany, M. G., Yanovski, J. A., Liang, T. J., & Hoofnagle, J. H. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.005 · Cited by 90
Hepatocellular Injury in a Patient Receiving Pioglitazone
Maeda, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00029 · Cited by 90
Cassader, M., Gambino, R., Musso, G., Depetris, N., Mecca, F., Cavallo‐Perin, P., Pacini, G., Rizzetto, M., & Pagano, G. (2001) · Lipids · doi:10.1007/s11745-001-0822-5 · Cited by 88
Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection.
Özyılkan, E., & Arslan, M. (1996) · PubMed · Cited by 87
Prospective study of diabetes mellitus and liver cancer in Japan
Fujino, Y., Mizoue, T., Tokui, N., & Yoshimura, T. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.214 · Cited by 85
Chan, K. A., Truman, A. F., Gurwitz, J. H., Hurley, J. S., Martinson, B. C., Platt, R. G., Everhart, J. E., Moseley, R. H., Terrault, N. A., Ackerson, L., et al. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.6.728 · Cited by 75
Balkau, B., Eschwège, É., Ducimetère, P., Richard, J.-L., & Warnet, J. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90209-r · Cited by 74
Bonkovsky, H. L., Azar, R. R., Bird, S. B., Szabó, G., & Banner, B. F. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015895925374 · Cited by 67
Review article: drug therapy for non‐alcoholic fatty liver disease
Comar, K. M., & Sterling, R. K. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02751.x · Cited by 66
Gentile, S., Turco, S., Guarino, G., Oliviero, B., Annunziata, S., Cozzolino, D., Sasso, F. C., Turco, A., Salvatore, T., & Torella, R. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00103.x · Cited by 66
Interferon induces insulin resistance in patients with chronic active hepatitis C
Imano, E., Kanda, T., Ishigami, Y., Kubota, M., Ikeda, M., Matsuhisa, M., Kawamori, R., & Yamasaki, Y. (1998) · Journal of Hepatology · doi:10.1016/0168-8278(88)80004-7 · Cited by 65
Glucose resistance contributes to diabetes mellitus in cirrhosis
Petrides, A. S., Schulze-Berge, D., Vogt, C., Matthews, D. E., & Strohmeye, G. (1993) · Hepatology · doi:10.1002/hep.1840180210 · Cited by 57
Fulminant hepatitis after lisinopril administration
Larrey, D. G., Babany, G., Bernuau, J., Andrieux, J., Degott, C., Pessayre, D., & Benhamou, J. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90496-n · Cited by 55
Atorvastatin for the treatment of NASH
HORTANDER, J., Kwo, P. Y., Cummings, O. W., et al. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)82704-7 · Cited by 54
Hepatic Injury Caused by Acarbose
Andrade, R. J., Lucena, M. I., & Rodriguez-Mendizabal, M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-10-199605150-00030 · Cited by 52
Pioglitazone-associated fulminant hepatic failure
Chase, M. P., & Yarze, J. C. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05516.x · Cited by 52
Losartan-Induced Hepatic Injury
Tabak, F., Mert, A., Özaras, R., Biyikli, M., Ozturk, R., Özbay, G., Şentürk, H., & Aktuğlu, Y. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200205000-00022 · Cited by 51
Liver failure in a patient treated with long-term rosiglitazone therapy
Gouda, H. E., Khan, A., Schwartz, J., & Cohen, R. I. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00926-3 · Cited by 48
Acarbose-Induced Acute Hepatitis
Díaz-Gutiérrez, F., Ladero, J. M., & Díaz‐Rubio, M. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.481_1.x · Cited by 47
Burge, M. R., Zeise, T. M., Sobhy, T. A., Rassam, A. G., & Schade, D. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.2037 · Cited by 46
Zatloukal, K., Böck, G., Rainer, I., Denk, H., & Weber, K. (1991) · PubMed · Cited by 41
Belcher, G., & Schernthaner, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01595.x · Cited by 39
Ito, Y., Takeda, N., Ishimori, M., Akai, A., Miura, K., & Yasuda, K. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80216-5 · Cited by 34
Hui, J. M., & Farrell, G. C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03170.x · Cited by 30
Microsatellite instability in human hepatocellular carcinoma: relationship to p53 abnormalities
Kazachkov, Y., Yoffe, B., Khaoustov, V. I., et al. (1998) · Liver International · doi:10.1111/j.1600-0676.1998.tb00143.x · Cited by 28
Increased Liver Chemistry in an Asymptomatic Patient
Goessling, W., & Friedman, L. S. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00416-7 · Cited by 24
Talley, N. J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02043.x · Cited by 19
Ratziu, V., Charlotte, F., Jacqueminet, S., Giral, P., Podevin, P., Serfaty, L., Bruckert, É., & Poynard, T. (2006) · Journal of Hepatology · doi:10.1016/s0168-8278(06)80738-5 · Cited by 17
Chlorpropamide-induced cholestatic jaundice and pseudomembranous colitis.
Gupta, R., & Sachar, D. B. (1985) · PubMed · Cited by 15
Lindor, K. D. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)83579-5 · Cited by 15
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
The burden and risks of emerging complications of diabetes mellitus
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00690-7 · Cited by 1,163
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,133
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Metadata
- Authors
- Tolman, K. G., Fonseca, V., Dalpiaz, A., & Tan, M. H.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-03-01
- Volume
- 30
- Issue
- 3
- Pages
- 734-743
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2039963918
- Cited by
- 525
- References
- 146
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.